| Tumor Type | miRNA up-regulated | miRNA down-regulated | Samples Setting | Methods | References |
| Lymphoma CNS | -21, -19b, -92a | CNS DLBCL vs Inflammatory CNS disorders | qRT-PCR | [21] | |
| -21, -19b | -16, -127 | CNS DLBCL vs extranodal DLBCL | qRT-PCR and ISH | [64] | |
| -9, -20b, -155, -340, -17-5p, -148a | -199a, -214, -432, -193b, -145 | CNS DLBCL vs LN DLBCL | qRT-PCR | [61] | |
| Meningioma | -335, -98, -181a, -19b, let7d, let7g, -100, -125a, -103, -370, -106b, -106a, -125b, let7b, -26a, -23b, -29a | -200a, -373*, -575 | Meningioma vs Normal Brain | Microarray and qRT-PCR | [45] |
| -145, let-7d | Meningioma vs Normal Brain | qRT-PCR | [36] | ||
| -145 | G2-G3 vs G1 | [36] | |||
| -335 | Meningioma vs Normal Brain | qRT-PCR | [46] | ||
| -17-5p, -22-3p, -24-3p, -26b-5p, -27a-3p, -27b-3p, -96-5p, -146a-5p, -155-5p, -186-5p, -190a, -199a | -29c-3p, -219-5p | Meningioma vs Normal Brain | qRT-PCR | [54] | |
| -96-5p, -190a | Patients with Recurrence vs Without | [54] | |||
| -29c-3p, -219-5p | Patients Without Recurrence vs With Recurrence | [54] | |||
| Pituitary Adenomas | -26a, -149 | -21, -141, -144 | Pituitary Adenomas vs normal | Microarray | [22] |
| -320 | -34b, -326, -374b, -432, -548c-3p, -570, -603, -33 | GH-adenomas vs normal | Microarray | [27] | |
| -183, -193a-5p, -222, -516b, -524-5p, -601, -629, -99b | -124, -32, -574-5p, -744, -96 | Macro- vs Micro-adenomas | Microarray | [41] | |
| -135a, -140-5p, -582-3p, -582-5p, -938, -124*, -515-5p, -872 | -198, -299-5p, -497*, -548c-3p, -622 | Pituitary Adenomas vs normal | qRT-PCR | [23] | |
| -378, -516-3p, -151-3p, -224, -618, -455-3p, -29b | -509-3-5p, -508-5p, -452, -330-5p, -200a, -503, -424, -449a, -199-5p | Pituitary Adenomas vs normal | qRT-PCR | [51] | |
| -217, -216a, -215, -502, -338, -10b, -96, -202, -501, -18a, -450a, -329 | Non-functioning pituitary adenoma | [51] | |||
| -1, -760, -196b, -188-5p, -146b-3p | GH-adenoma | [51] | |||
| -205, -132*, -523 | PRL-adenoma | [51] |